BLU News and Press, BELLUS Health Inc. From 11/27/20

Billionaire investor Warren Buffett advises people not to time the market , because it’s a useless exercise. However, his recent buys seem to suggest he’s timing for something else — the COVID-19 vaccine. Berkshire Hathaway bought four pharma stocks in the t...

BELLUS Health Inc. (Nasdaq:BLU; TSX:BLU) (“BELLUS Health” or the “Company”), a clinical-stage biopharmaceutical company developing novel therapeutics for the treatment of chronic cough and other hypersensitization-related disorders, today announced that Rober...

Are These Biotech Penny Stocks On Your Watch List Today? Have you seen some of the biotech penny stocks today? If not, you might want to take a peek at the sector itself. With news from Pfizer that its final results on a coronavirus vaccine recorded 95% efficacy, traders are on the ...

Gainers: Phoenix Tree (DNK) +91%.Naked Brand (NAKD) +64%.Kazia Therapeutics (KZIA) +32%.Micro Focus International (MFGP) +32%.BELLUS Health (BLU) +31%.InnSuites Hospitality Trust (IHT) +27%.FuelCell Energy (FCEL) +27%.Ashford Hospitality Trust (AHT) +24%.CIIG Merger (CIIC) ...

BELLUS Health (BLU) is on watch after Evercore ISI starts off coverage with an Outperform rating. In a nutshell, analyst Josh Schimmer and team think the market dramatically underestimates the results of a key study. "The P2 study of ‘5937 missed its primary endpoint, driving shares su...

VAALCO Energy (EGY) +39% as it agrees to acquire Sasol's 27.8% working interest in the Etame Marin block offshore Gabon.Socket Mobile (SCKT) +39% on contactless reader clearing Google Wallet Certification.Micro Focus International (MFGP) +31%.Phoenix Tree Holdings (DNK) +2...

BELLUS Health (BLU): Q3 GAAP EPS of -$0.09 beats by $0.05.Revenue of $3K (-57.1% Y/Y).Press Release For further details see: BELLUS Health EPS beats by $0.05

- Following a recent FDA meeting, the Phase 2b SOOTHE trial in refractory chronic cough patients remains on track to initiate in Q4 2020 - - The Phase 2 BLUEPRINT trial in chronic pruritus associated with atopic dermatitis remains on track to initiate in Q4 2020 - ...

BELLUS Health Inc. (Nasdaq:BLU; TSX:BLU) (“BELLUS Health” or the “Company”), a clinical-stage biopharmaceutical company developing novel therapeutics for the treatment of chronic cough and other hypersensitization-related disorders, today announced that Rober...

Biotech Penny Stocks To Watch This Week Looking for top penny stocks to watch this week? You’re not alone. One of the hotter sectors to watch in the stock market today is biotech and healthcare. I’m not just saying that because coronavirus vaccines remain a hot button ...